OM

Opaleye Management Portfolio holdings

AUM $707M
1-Year Est. Return 67.55%
This Quarter Est. Return
1 Year Est. Return
+67.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$707M
AUM Growth
+$213M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1 +$14.4M
2 +$13.5M
3 +$7.93M
4
DERM icon
Journey Medical
DERM
+$6.24M
5
SLGL icon
Sol-Gel Technologies
SLGL
+$5.97M

Top Sells

1 +$7.95M
2 +$6.23M
3 +$5.9M
4
DNA icon
Ginkgo Bioworks
DNA
+$5.63M
5
IMNM icon
Immunome
IMNM
+$4.04M

Sector Composition

1 Healthcare 99.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLX icon
26
Protalix BioTherapeutics
PLX
$143M
$5.73M 0.81%
+2,580,556
TMCI icon
27
Treace Medical Concepts
TMCI
$190M
$4.71M 0.67%
+702,245
RVMD icon
28
Revolution Medicines
RVMD
$15B
$4.67M 0.66%
100,000
-5,000
MBX
29
MBX Biosciences
MBX
$1.55B
$4.43M 0.63%
253,000
+13,681
TRVI icon
30
Trevi Therapeutics
TRVI
$1.69B
$3.57M 0.5%
390,000
ADCT icon
31
ADC Therapeutics
ADCT
$533M
$2.73M 0.39%
+682,529
ALMS
32
Alumis Inc
ALMS
$801M
$2.65M 0.38%
665,000
-110,000
CABA icon
33
Cabaletta Bio
CABA
$247M
$1.89M 0.27%
+808,882
IRD
34
Opus Genetics
IRD
$147M
$1.81M 0.26%
1,100,000
-120,000
ZYME icon
35
Zymeworks
ZYME
$2.01B
$1.71M 0.24%
100,000
-110,000
SYRE icon
36
Spyre Therapeutics
SYRE
$2.33B
$1.09M 0.15%
+65,000
RIGL icon
37
Rigel Pharmaceuticals
RIGL
$916M
$1.07M 0.15%
+37,787
ACOG
38
Alpha Cognition
ACOG
$131M
$750K 0.11%
+115,142
ZNTL icon
39
Zentalis Pharmaceuticals
ZNTL
$103M
$478K 0.07%
316,550
-1,607,750
PEPG icon
40
PepGen
PEPG
$443M
$347K 0.05%
75,000
-165,000
IBIO icon
41
iBio
IBIO
$27.7M
$310K 0.04%
375,000
ADGM
42
Adagio Medical Holdings
ADGM
$17M
$215K 0.03%
110,571
ANIK icon
43
Anika Therapeutics
ANIK
$142M
-588,797
CRGX
44
DELISTED
CARGO Therapeutics
CRGX
-666,503
DNA icon
45
Ginkgo Bioworks
DNA
$562M
-500,000
ELEV
46
DELISTED
Elevation Oncology
ELEV
-1,442,061
EPIX
47
DELISTED
ESSA Pharma
EPIX
-2,209,998
RCEL icon
48
Avita Medical
RCEL
$113M
-389,519
TARA icon
49
Protara Therapeutics
TARA
$285M
-855,000
VIGL
50
DELISTED
Vigil Neuroscience
VIGL
-1,000,000